以光驱动的微机器人用于有针对性的药物输送
Qilong Cheng1, Xingqi Lu1, Yunhao Tai1
1School of Biomedical Engineering, Anhui Medical University, Hefei 230032, China.
ACS biomaterials science & engineering
|August 15, 2024
概括
以光驱动的微机器人为生物医学应用提供了精确的非接触式控制,例如药物向. 这篇评论探讨了它们的机制,设计和未来在医学中的潜力.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 机器人技术 机器人技术 机器人技术
背景情况:
- 光驱动的微机器人是生物医学领域精确操纵的新兴工具.
- 光场控制提供了诸如无接触操作,精确定位和生物相容性等优势.
研究的目的:
- 为药物向应用提供光驱动微机器人的概述.
- 探索使用光场进行微机器人操纵的新想法.
主要方法:
- 驱动机制 (光热,光化学,生物) 和材料的分类.
- 在多个物理领域的微机器人设计和控制策略的总结.
- 对药物向和生物成像当前应用的审查.
主要成果:
- 光场可以通过光诱导的力或变形来精确控制微机器人.
- 与药物释放技术的整合有助于有针对性的药物输送.
- 针对各种应用,正在开发不同的设计和控制策略.
结论:
- 以光驱动的微机器人显示出针对药物输送和生物成像的重大前景.
- 对驱动机制,材料和控制策略的进一步研究至关重要.
- 这些微机器人代表了先进的生物医学操纵有前途的未来.
相关概念视频
Drug Delivery: Overview
1.3K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.3K
Modified-Release Drug Delivery Systems: Rate-Programmed II
139
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
139
Modified-Release Drug Delivery Systems: Rate-Programmed I
174
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
174
Modified-Release Drug Delivery Systems: Stimuli-Activated
184
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
184
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165


